Dementia
Using Real-World Data to Close Treatment Gaps in Alzheimer’s Disease and Related Dementias
PointClickCare Life Sciences
PAO-12-25-CL-03Dec 11, 2025
Health Equity
Bridging the Gap: Advancing Access to New Medications for Older Adults in Long-Term Care
PointClickCare Life Sciences
PAO-11-25-CL-07Nov 24, 2025
Alzheimer's
Enhanced Genomics and The ALBORADA Drug Discovery Institute Partner to Accelerate Alzheimer's Drug Discovery
Enhanced Genomics
PR-06-25-NI-08Jun 24, 2025
Clinical Results
ACADIA Pharmaceuticals Presents Positive Top-line Results from Dementia-Related Psychosis Trial
Acadia Pharmaceuticals
PR-M12-19-NI-012Dec 6, 2019
Dementia
Single Gene Identified as Culprit in Early-Onset Dementia
Pharma's Almanac
PAO-M12-18-NI-016Dec 19, 2018
Drug Designation
Alector Receives Orphan Drug Designation from the U.S. FDA for AL001 for the Treatment of Frontotemporal Dementia
Alector
PR-M08-18-NI-080Aug 21, 2018